A 24-minute survey of robotic platforms for endoscopic submucosal dissection — from EndoMASTER and EASE through STRAS, K-FLEX, Flex Robotic, Endomina, EndoFaster, GIFTS/ROBOPERA, Da Vinci SP, and EndoQuest ELS — with the Genidy 2026 meta-analysis, the drawbacks nobody wants to talk about, and a realistic clinical roadmap.
The talk's closing vision — a realistic 5-to-10-year timeline for robotic ESD democratisation and the signature quote from Professor V. Ho about blurring the lines between surgery and endoscopy. Self-contained, memorable, and captures the lecture's core message.
"We're all making our own things to do our attraction, but there is nothing that is systematic and that is structured, just like laparoscopic surgery, where you can lift the megalosal flap out of the way to get another hand in play."
ESD is technically demanding — adoption is limited by long learning curves (50 to 1,000 cases depending on who you ask), by the ergonomic burden on the endoscopist, and by the absence of a systematic, structured way to apply counter-traction during dissection. This 24-minute lecture asks whether robotic platforms can finally close those gaps, surveys every credible candidate, and lays out a pragmatic clinical roadmap.
"This one got FDA approval in 2017, but the company went bust. The financials of creating a robotic endoscopy company are not particularly solid."
A conventional endoscope has four degrees of freedom: push-pull, up-down, left-right, and rotation around its axis. Anything moving freely in 3D has six. A single robotic arm can add another seven to ten, and dual-arm robotic platforms inherit the endoscope's four and then layer joints on top — giving the operator something closer to two hands in the game instead of one. That extra dexterity, combined with structured traction and improved ergonomics, is what robotics promises to bring to ESD.
"There's no room for a robot in it. There's hardly room for me in it."
"The future of endoscopic surgery is to blur the lines between surgery and endoscopy to give the endoscopist the power to cut and mend."
The Genidy 2026 meta-analysis pooled 115 patients across robotic ESD series. Heterogeneity is maximal and the numbers are small, but in the hands of expert interventional endoscopists — mostly at university centres — complete resection, R0 resection, and intraoperative metrics are solid. A separate randomised trial of five ESD-naïve endoscopists comparing conventional to robotic ESD found shorter procedure times, lower perforation rates, and better ergonomics in the robot arm. The study is small and platform-specific, but the signal is real: robotic platforms may flatten the ESD learning curve and standardise practice.
Looking forward, combine a robotic platform with current AI capabilities and you can imagine real-time vessel avoidance, highlighted safety planes, automatic KPI reporting, and in-procedure performance feedback. Most of these individual capabilities already exist; integrating them into one workflow is the next obvious step.
First FDA-approved robotic ESD device likely 2027. Specialist-centre uptake in the years that follow. Meaningful democratisation to community practice: 5-to-10 years. Near-term, the most actionable gain is not a robot at all — it's adopting a reliable traction device and figuring out how it integrates into standard ESD practice. The evidence base is small and needs real-world data from outside the university setting.
Interventional endoscopists, ESD trainees, and anyone on a hospital's endoscopy equipment committee who needs a grounded, 24-minute map of the robotic ESD landscape — what's real, what's vaporware, and where the field is actually going over the next decade.
Access the full course with expert demonstrations, case studies, and clinical pearls.